These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 16169448)

  • 1. Attention deficit/hyperactivity disorder and psychopharmacologic treatments in the athlete.
    Conant-Norville DO; Tofler IR
    Clin Sports Med; 2005 Oct; 24(4):829-43, viii. PubMed ID: 16169448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Attention-deficit-hyperactivity disorder: an update.
    Dopheide JA; Pliszka SR
    Pharmacotherapy; 2009 Jun; 29(6):656-79. PubMed ID: 19476419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medications for adolescents with attention-deficit/hyperactivity disorder.
    Soileau EJ
    Adolesc Med State Art Rev; 2008 Aug; 19(2):254-67, viii-ix. PubMed ID: 18822831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Attention deficit hyperactivity disorder in sport: a review.
    Corrigan B
    Int J Sports Med; 2003 Oct; 24(7):535-40. PubMed ID: 12968213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adults with attention deficit hyperactivity disorder: assessment and treatment considerations.
    Murphy K
    Semin Speech Lang; 1996 Aug; 17(3):245-53; quiz 254. PubMed ID: 8912439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Health-related quality of life in methylphenidate-treated children with attention-deficit-hyperactivity disorder: results from a Taiwanese sample.
    Yang P; Hsu HY; Chiou SS; Chao MC
    Aust N Z J Psychiatry; 2007 Dec; 41(12):998-1004. PubMed ID: 17999272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ADHD and the rise in stimulant use among children.
    Mayes R; Bagwell C; Erkulwater J
    Harv Rev Psychiatry; 2008; 16(3):151-66. PubMed ID: 18569037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relative benefits of stimulant therapy with OROS methylphenidate versus mixed amphetamine salts extended release in improving the driving performance of adolescent drivers with attention-deficit/hyperactivity disorder.
    Cox DJ; Merkel RL; Moore M; Thorndike F; Muller C; Kovatchev B
    Pediatrics; 2006 Sep; 118(3):e704-10. PubMed ID: 16950962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transition from methylphenidate or amphetamine to atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder--a preliminary tolerability and efficacy study.
    Quintana H; Cherlin EA; Duesenberg DA; Bangs ME; Ramsey JL; Feldman PD; Allen AJ; Kelsey DK
    Clin Ther; 2007 Jun; 29(6):1168-77. PubMed ID: 17692731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of the adrenergic alpha2A receptor gene with methylphenidate improvement of inattentive symptoms in children and adolescents with attention-deficit/hyperactivity disorder.
    Polanczyk G; Zeni C; Genro JP; Guimarães AP; Roman T; Hutz MH; Rohde LA
    Arch Gen Psychiatry; 2007 Feb; 64(2):218-24. PubMed ID: 17283289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ADHD in children, adolescents, and adults.
    Katragadda S; Schubiner H
    Prim Care; 2007 Jun; 34(2):317-41; abstract viii. PubMed ID: 17666230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An update on central nervous system stimulant formulations in children and adolescents with attention-deficit/hyperactivity disorder.
    Chavez B; Sopko MA; Ehret MJ; Paulino RE; Goldberg KR; Angstadt K; Bogart GT
    Ann Pharmacother; 2009 Jun; 43(6):1084-95. PubMed ID: 19470858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evolution of the treatment of attention-deficit/hyperactivity disorder in children: a review.
    Findling RL
    Clin Ther; 2008 May; 30(5):942-57. PubMed ID: 18555941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Attention-deficit/hyperactivity disorder: a personal perspective.
    Ginsberg ML
    Adolesc Med State Art Rev; 2008 Aug; 19(2):339-51, xi-xii. PubMed ID: 18822837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stimulant therapy in attention deficit/hyperactivity disorder.
    Baldwin RL
    J Ark Med Soc; 2003 Dec; 100(6):203-6. PubMed ID: 14661403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of comorbid autism spectrum disorders on stimulant response in children with attention deficit hyperactivity disorder: a retrospective and prospective effectiveness study.
    Santosh PJ; Baird G; Pityaratstian N; Tavare E; Gringras P
    Child Care Health Dev; 2006 Sep; 32(5):575-83. PubMed ID: 16919137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
    Spencer TJ; Wilens TE; Biederman J; Weisler RH; Read SC; Pratt R
    Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A controlled trial of methylphenidate in adults with attention deficit/hyperactivity disorder and substance use disorders.
    Carpentier PJ; de Jong CA; Dijkstra BA; Verbrugge CA; Krabbe PF
    Addiction; 2005 Dec; 100(12):1868-74. PubMed ID: 16367988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The effects of methylphenidate on various components of visual attention in children with attention-deficit hyperactivity disorder].
    Durukan I; Türkbay T; Cöngöloğlu A
    Turk Psikiyatri Derg; 2008; 19(4):358-64. PubMed ID: 19110977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Graphomotor functions in children with attention deficit hyperactivity disorder (ADHD)].
    Stasik D; Tucha O; Tucha L; Walitza S; Lange KW
    Psychiatr Pol; 2009; 43(2):183-92. PubMed ID: 19697788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.